These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 35342405)
1. Identifying the Potential Role and Prognostic Value of the Platelet-Derived Growth Factor Pathway in Kidney Renal Clear Cell Carcinoma. Xin S; Sun X; Jin L; Zhou Z; Liu X; Li W; Mei W; Zhang J; Zhang B; Yao X; Zhou L; Ye L J Oncol; 2022; 2022():9498010. PubMed ID: 35342405 [TBL] [Abstract][Full Text] [Related]
2. Establishment of a new prognostic risk model of MAPK pathway-related molecules in kidney renal clear cell carcinoma based on genomes and transcriptomes analysis. Zhang P; Li J; Wang Z; Zhao L; Qiu J; Xu Y; Wu G; Xia Q Front Oncol; 2023; 13():1077309. PubMed ID: 36969076 [TBL] [Abstract][Full Text] [Related]
3. The Role of ERBB Signaling Pathway-Related Genes in Kidney Renal Clear Cell Carcinoma and Establishing a Prognostic Risk Assessment Model for Patients. Wang Z; Li J; Zhang P; Zhao L; Huang B; Xu Y; Wu G; Xia Q Front Genet; 2022; 13():862210. PubMed ID: 35903358 [No Abstract] [Full Text] [Related]
4. Development and Validation of Nine-RNA Binding Protein Signature Predicting Overall Survival for Kidney Renal Clear Cell Carcinoma. Zhong W; Huang C; Lin J; Zhu M; Zhong H; Chiang MH; Chiang HS; Hui MS; Lin Y; Huang J Front Genet; 2020; 11():568192. PubMed ID: 33133154 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic role of basic leucine zipper transcription factor in kidney renal clear cell carcinoma. Zhang H; Zhang H; Hu Y; Huang B; Chen J; Chen L Transl Androl Urol; 2022 Feb; 11(2):238-252. PubMed ID: 35280662 [TBL] [Abstract][Full Text] [Related]
6. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma. Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933 [TBL] [Abstract][Full Text] [Related]
7. Angiogenesis Pathway in Kidney Renal Clear Cell Carcinoma and Its Prognostic Value for Cancer Risk Prediction. Che X; Su W; Li X; Liu N; Wang Q; Wu G Front Med (Lausanne); 2021; 8():731214. PubMed ID: 34778292 [TBL] [Abstract][Full Text] [Related]
8. Identification of small molecule drugs and development of a novel autophagy-related prognostic signature for kidney renal clear cell carcinoma. Xing Q; Ji C; Zhu B; Cong R; Wang Y Cancer Med; 2020 Oct; 9(19):7034-7051. PubMed ID: 32780567 [TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma. Sun Y; Xu Y; Che X; Wu G Front Cell Dev Biol; 2022; 10():881490. PubMed ID: 35846357 [TBL] [Abstract][Full Text] [Related]
10. Decreased expression of HADH is related to poor prognosis and immune infiltration in kidney renal clear cell carcinoma. Jiang H; Chen H; Wan P; Chen N Genomics; 2021 Nov; 113(6):3556-3564. PubMed ID: 34391866 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy. Xiong X; Chen C; Yang J; Ma L; Wang X; Zhang W; Yuan Y; Peng M; Li L; Luo P Front Oncol; 2022; 12():1024956. PubMed ID: 36439501 [TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
13. The potential value of the Purinergic pathway in the prognostic assessment and clinical application of kidney renal clear cell carcinoma. Xie D; Wang S; Jiang B; Li G; Wu G Aging (Albany NY); 2024 Jan; 16(1):246-266. PubMed ID: 38180750 [TBL] [Abstract][Full Text] [Related]
14. Identification of a Necroptosis-Related Prognostic Index and Associated Regulatory Axis in Kidney Renal Clear Cell Carcinoma. Luo Y; Zhang G Int J Gen Med; 2022; 15():5407-5423. PubMed ID: 35685693 [TBL] [Abstract][Full Text] [Related]
15. Construction of an endoplasmic reticulum stress-related gene model for predicting prognosis and immune features in kidney renal clear cell carcinoma. Shen Y; Cao Y; Zhou L; Wu J; Mao M Front Mol Biosci; 2022; 9():928006. PubMed ID: 36120545 [No Abstract] [Full Text] [Related]
16. Identification of Survival Risk and Immune-Related Characteristics of Kidney Renal Clear Cell Carcinoma. Wu X; Liang Y; Chen X; Long X; Xu W; Liu L; Wang B; Zou X J Immunol Res; 2022; 2022():6149369. PubMed ID: 35832648 [TBL] [Abstract][Full Text] [Related]
17. A microRNA-clinical prognosis model to predict the overall survival for kidney renal clear cell carcinoma. Zhan Y; Zhang R; Li C; Xu X; Zhu K; Yang Z; Zheng J; Guo Y Cancer Med; 2021 Sep; 10(17):6128-6139. PubMed ID: 34288551 [TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of MFN2 as a prognostic biomarker associated with immune cell infiltration in renal clear cell carcinoma. Cheng L; Wang Z; Nie L; Yang C; Huang H; Lin J; Zhuo D Int Immunopharmacol; 2022 Oct; 111():109169. PubMed ID: 36007389 [TBL] [Abstract][Full Text] [Related]
19. Upregulated Transcription Factor PITX1 Predicts Poor Prognosis in Kidney Renal Clear Cell Carcinoma-Based Bioinformatic Analysis and Experimental Verification. Zhang Y; Zhang Z; Zhang W; Hu H; Bao G Dis Markers; 2021; 2021():7694239. PubMed ID: 34868397 [TBL] [Abstract][Full Text] [Related]